查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463101

孟鲁司特钠市场、占有率、规模、趋势、产业分析报告：依产品类型、剂型、应用、地区、细分市场预测，2024-2032

Montelukast Sodium Market Share, Size, Trends, Industry Analysis Report, By Product Type (Montelukast Sodium Amorphous and Montelukast Sodium Crystalline); By Dosage Form; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球孟鲁司特钠市场规模将达到7.7378亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于促进其扩张的几个关键因素，孟鲁司特钠市场呈现稳定成长。 孟鲁司特钠是一种白三烯受体拮抗剂，主要用于控制和预防气喘症状以及缓解过敏性鼻炎症状。 它对这些症状的有效性为全球市场的扩张做出了重大贡献。 此外，全球气喘和过敏性鼻炎盛行率的上升也刺激了对孟鲁司特钠的需求。 随着医疗保健意识的提高和诊断能力的提高，越来越多的人被诊断出患有这些疾病，进一步推动了市场的成长。

此外，製药公司专注于研发活动以扩大孟鲁司特钠的应用也是市场成长的主要推动力。 这些努力旨在探索其他呼吸系统疾病的潜在治疗方法，例如运动引起的支气管收缩和慢性阻塞性肺病（COPD），从而扩大市场基础。 此外，孟鲁司特钠的安全性和有效性使其越来越多地在儿科人群中采用，进一步推动了市场扩张。

此外，各地区对孟鲁司特钠製剂的监管批准不断增加，也推动了孟鲁司特钠的采用并有助于市场扩张。 孟鲁司特钠仿製药的出现在提高市场渗透率方面也发挥着重要作用，特别是在负担能力和可及性成为关键问题的新兴市场。

区域分析显示，北美目前占孟鲁司特钠市场的主要占有率，这主要是由于该地区气喘和过敏性鼻炎的高盛行率以及完善的医疗基础设施的存在。 然而，预计亚太地区在预测期内将呈现巨大的成长机会。 中国和印度等国家的医疗成本上升、人们对呼吸系统疾病的认识不断提高以及患者人数不断增加等因素预计将推动该地区的市场成长。

孟鲁司特钠市场报告亮点

孟鲁司特钠无定形片段在2023年占最大占有率，广泛用于预防呼吸系统疾病。

片剂细分市场在 2023 年占最大占有率，因为它具有易于运输、剂量准确和污染机会较小等许多优点。

由于全球气喘盛行率不断上升以及人们对可用治疗方案的认识不断提高，气喘细分市场将在 2023 年引领市场。

由于呼吸道疾病盛行率上升以及发现新应用的研究活动增加，北美将在 2023 年主导全球市场

主要市场参与者包括 Sandoz International、Sun Pharmaceutical Industries、Merck、Cipla、Aurobindo Pharma 等。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章孟鲁司特钠全球市场洞察

  • 孟鲁司特钠市场 - 应用概况
  • 孟鲁司特钠市场动态
    • 推动者和机会
      • 人口老化加剧推动市场成长
      • 饮食习惯的变化和快速城市化推动市场成长
    • 抑制因素和课题
      • 与孟鲁司特相关的副作用
  • PESTEL 分析
  • 孟鲁司特钠市场应用趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第五章以剂型划分的世界市场

  • 主要发现
  • 简介
  • 平板电脑
  • 咀嚼片
  • 口服溶液

第 6 章全球市场（依产品类型）

  • 主要发现
  • 简介
  • 无定形孟鲁司特钠
  • 孟鲁司特钠晶体

第 7 章依应用划分的世界市场

  • 主要发现
  • 简介
  • 气喘
  • 过敏性鼻炎荨麻疹
  • 其他

第 8 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年孟鲁司特钠市场评估（依地区）
  • 孟鲁司特钠市场 - 北美
    • 北美：孟鲁司特钠市场，依剂型，2019-2032
    • 北美：孟鲁司特钠市场，依应用划分，2019-2032 年
    • 北美：孟鲁司特钠市场，依产品类型，2019-2032 年
    • 孟鲁司特钠市场 - 美国
    • 孟鲁司特钠市场 - 加拿大
  • 孟鲁司特钠市场 - 欧洲
    • 欧洲：孟鲁司特钠市场，依剂型，2019-2032 年
    • 欧洲：孟鲁司特钠市场，依应用划分，2019-2032 年
    • 欧洲：孟鲁司特钠市场，依产品类型，2019-2032 年
    • 孟鲁司特钠市场 - 英国
    • 孟鲁司特钠市场－法国
    • 孟鲁司特钠市场－德国
    • 孟鲁司特钠市场 - 义大利
    • 孟鲁司特钠市场－西班牙
    • 孟鲁司特钠市场－荷兰
    • 孟鲁司特钠市场－俄罗斯
  • 孟鲁司特钠市场－亚太地区
    • 亚太地区：孟鲁司特钠市场，依剂型，2019-2032 年
    • 亚太地区：孟鲁司特钠市场，依应用划分，2019-2032 年
    • 亚太地区：孟鲁司特钠市场，依产品类型，2019-2032 年
    • 孟鲁司特钠市场－中国
    • 孟鲁司特钠市场－印度
    • 孟鲁司特钠市场 - 马来西亚
    • 孟鲁司特钠市场-日本
    • 孟鲁司特钠市场-印度尼西亚
    • 孟鲁司特钠市场-韩国
  • 孟鲁司特钠市场－中东和非洲
    • 中东和非洲：孟鲁司特钠市场，依剂型，2019-2032 年
    • 中东和非洲：孟鲁司特钠市场，依应用划分，2019-2032 年
    • 中东和非洲：2019-2032 年孟鲁司特钠市场（依产品类型）
    • 孟鲁司特钠市场-沙乌地阿拉伯
    • 孟鲁司特钠市场－阿联酋
    • 孟鲁司特钠市场 - 以色列
    • 孟鲁司特钠市场－南非
  • 孟鲁司特钠市场 - 拉丁美洲
    • 拉丁美洲：孟鲁司特钠市场，依剂型，2019-2032 年
    • 拉丁美洲：孟鲁司特钠市场，依应用划分，2019-2032 年
    • 拉丁美洲：孟鲁司特钠市场，依产品类型，2019-2032 年
    • 孟鲁司特钠市场 - 墨西哥
    • 孟鲁司特钠市场－巴西
    • 孟鲁司特钠市场-阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第十章公司简介

  • Apotex Inc.（Canada）
  • .Aurobindo Pharma Ltd.（India）
  • Cipla Ltd.（India）
  • Glenmark Pharmaceutical Ltd.（India）
  • Jubilant Life Sciences Ltd.（India）
  • Merck & Co. Inc.（US）
  • Mylan N.V.（US）
  • Sandoz International GmbH（Germany）
  • Sun Pharmaceutical Industries Ltd.（India）
  • Teva Pharmaceutical Industries Ltd.（Israel）
Product Code: PM4778

The global montelukast sodium market size is expected to reach USD 773.78 million by 2032, according to a new study by Polaris Market Research. The report "Montelukast Sodium Market Share, Size, Trends, Industry Analysis Report, By Product Type (Montelukast Sodium Amorphous and Montelukast Sodium Crystalline); By Dosage Form; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Montelukast Sodium market is witnessing steady growth owing to several key factors driving its expansion. Montelukast Sodium, a leukotriene receptor antagonist, is primarily used to manage and prevent asthma symptoms and to relieve symptoms of allergic rhinitis. Its efficacy in treating these conditions has contributed significantly to the expansion of the global market. Additionally, the rise in the prevalence of asthma and allergic rhinitis cases worldwide has fueled the demand for Montelukast Sodium. As healthcare awareness continues to increase and diagnostic capabilities improve, more individuals are being diagnosed with these conditions, further boosting the market's growth.

Furthermore, the growing focus on research and development activities by pharmaceutical companies to expand the application of Montelukast Sodium is a significant driver of market growth. These efforts aim to explore its potential in treating other respiratory conditions, such as exercise-induced bronchoconstriction and chronic obstructive pulmonary disease (COPD), thus widening its market scope. Additionally, the increasing adoption of Montelukast Sodium in pediatric populations, owing to its safety and efficacy profiles, has further propelled market expansion.

Moreover, the market is witnessing favorable regulatory approvals for Montelukast Sodium formulations in various regions, which have facilitated its widespread availability and contributed to market growth. The emergence of generic versions of Montelukast Sodium has also played a crucial role in expanding market penetration, particularly in developing regions where affordability and accessibility are key concerns.

In terms of regional analysis, North America currently holds a significant share of the Montelukast Sodium market, primarily attributed to the high prevalence of asthma and allergic rhinitis in the region and the presence of established healthcare infrastructure. However, the Asia-Pacific region is anticipated to exhibit substantial growth opportunities during the forecast period. Factors such as the rising healthcare expenditure, increasing awareness about respiratory diseases, and the expanding patient population in countries like China and India are expected to drive market growth in this region.

Montelukast Sodium Market Report Highlights

Montelukast sodium amorphous segment accounted for largest share in 2023, owing to its widespread use to prevent respiratory diseases with greater efficacy

Tablets segment held the maximum share in 2023, that is attributed to its numerous benefits including easy transportation, accurate dosage, and low chance of contamination

Asthma segment led the market in 2023, due to growing incidences of asthma worldwide and awareness among people about the available treatment options of disease

North America dominated the global market in 2023, on account of rising prevalence of respiratory conditions and growing research activities to discover new uses

The key market players include Sandoz International, Sun Pharmaceutical Industries, Merck, Cipla, and Aurobindo Pharma

Polaris Market Research has segmented the montelukast sodium market report based on product type, dosage form, application, and region:

Montelukast Sodium, Product Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Montelukast Sodium Amorphous
  • Montelukast Sodium Crystalline

Montelukast Sodium, Dosage Form Outlook (Revenue - USD Million, 2023 - 2032)

  • Tablets
  • Chewable Tablets
  • Oral Solutions

Montelukast Sodium, Application Outlook (Revenue - USD Million, 2023 - 2032)

  • Asthma
  • Allergic Rhinitis Urticaria
  • Others

Montelukast Sodium, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Montelukast Sodium Market Insights

  • 4.1. Montelukast Sodium Market - Application Snapshot
  • 4.2. Montelukast Sodium Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing geriatric population to drive market growth
      • 4.2.1.2. Change in dietary habits and rapid urbanization to spur market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects associated with montelukast
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Montelukast Sodium Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Montelukast Sodium Market, by Dosage Form

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • 5.3. Tablets
    • 5.3.1. Global Montelukast Sodium Market, by Tablets, by Region, 2019-2032 (USD Million)
  • 5.4. Chewable Tablets
    • 5.4.1. Global Montelukast Sodium Market, by Chewable Tablets, by Region, 2019-2032 (USD Million)
  • 5.5. Oral Solutions
    • 5.5.1. Global Montelukast Sodium Market, by Oral Solutions, by Region, 2019-2032 (USD Million)

6. Global Montelukast Sodium Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 6.3. Montelukast Sodium Amorphous
    • 6.3.1. Global Montelukast Sodium Market, by Montelukast Sodium Amorphous, by Region, 2019-2032 (USD Million)
  • 6.4. Montelukast Sodium Crystalline
    • 6.4.1. Global Montelukast Sodium Market, by Montelukast Sodium Crystalline, by Region, 2019-2032 (USD Million)

7. Global Montelukast Sodium Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • 7.3. Asthma
    • 7.3.1. Global Montelukast Sodium Market, by Asthma, By Region, 2019-2032 (USD Million)
  • 7.4. Allergic Rhinitis Urticaria
    • 7.4.1. Global Montelukast Sodium Market, by Allergic Rhinitis Urticaria, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Montelukast Sodium Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Montelukast Sodium Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Montelukast Sodium Market - North America
    • 8.3.1. North America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.3.2. North America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.3.3. North America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.4. Montelukast Sodium Market - U.S.
      • 8.3.4.1. U.S.: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.5. Montelukast Sodium Market - Canada
      • 8.3.5.1. Canada: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.4. Montelukast Sodium Market - Europe
    • 8.4.1. Europe: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.4.3. Europe: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.4. Montelukast Sodium Market - UK
      • 8.4.4.1. UK: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.5. Montelukast Sodium Market - France
      • 8.4.5.1. France: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.3. France: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.6. Montelukast Sodium Market - Germany
      • 8.4.6.1. Germany: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.7. Montelukast Sodium Market - Italy
      • 8.4.7.1. Italy: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.8. Montelukast Sodium Market - Spain
      • 8.4.8.1. Spain: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.9. Montelukast Sodium Market - Netherlands
      • 8.4.9.1. Netherlands: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.10. Montelukast Sodium Market - Russia
      • 8.4.10.1. Russia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.5. Montelukast Sodium Market - Asia Pacific
    • 8.5.1. Asia Pacific: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.4. Montelukast Sodium Market - China
      • 8.5.4.1. China: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.3. China: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.5. Montelukast Sodium Market - India
      • 8.5.5.1. India: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.3. India: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.6. Montelukast Sodium Market - Malaysia
      • 8.5.6.1. Malaysia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.7. Montelukast Sodium Market - Japan
      • 8.5.7.1. Japan: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.8. Montelukast Sodium Market - Indonesia
      • 8.5.8.1. Indonesia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.9. Montelukast Sodium Market - South Korea
      • 8.5.9.1. South Korea: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.6. Montelukast Sodium Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.4. Montelukast Sodium Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.5. Montelukast Sodium Market - UAE
      • 8.6.5.1. UAE: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.6. Montelukast Sodium Market - Israel
      • 8.6.6.1. Israel: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.7. Montelukast Sodium Market - South Africa
      • 8.6.7.1. South Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.7. Montelukast Sodium Market - Latin America
    • 8.7.1. Latin America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.4. Montelukast Sodium Market - Mexico
      • 8.7.4.1. Mexico: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.5. Montelukast Sodium Market - Brazil
      • 8.7.5.1. Brazil: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.6. Montelukast Sodium Market - Argentina
      • 8.7.6.1. Argentina: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Apotex Inc. (Canada)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Aurobindo Pharma Ltd. (India)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Ltd. (India)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Glenmark Pharmaceutical Ltd. (India)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Jubilant Life Sciences Ltd. (India)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck & Co. Inc. (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan N.V. (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sandoz International GmbH (Germany)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sun Pharmaceutical Industries Ltd. (India)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teva Pharmaceutical Industries Ltd. (Israel)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 2 Global Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 3 Global Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 4 Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 6 North America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 7 North America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 8 U.S.: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 9 U.S.: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 11 Canada: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 12 Canada: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 13 Canada: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 14 Europe: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 15 Europe: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 16 Europe: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 17 UK: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 18 UK: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 19 UK: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 20 France: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 21 France: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 22 France: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 23 Germany: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 24 Germany: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 25 Germany: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 26 Italy: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 27 Italy: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 28 Italy: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 29 Spain: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 30 Spain: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 31 Spain: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 32 Netherlands: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 33 Netherlands: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 35 Russia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 36 Russia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 37 Russia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 41 China: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 42 China: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 43 China: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 44 India: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 45 India: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 46 India: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 47 Malaysia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 48 Malaysia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 50 Japan: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 51 Japan: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 52 Japan: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 53 Indonesia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 54 Indonesia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 56 South Korea: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 57 South Korea: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 65 UAE: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 66 UAE: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 67 UAE: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 68 Israel: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 69 Israel: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 70 Israel: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 71 South Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 72 South Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 74 Latin America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 75 Latin America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 77 Mexico: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 78 Mexico: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 80 Brazil: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 81 Brazil: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 83 Argentina: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 84 Argentina: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Montelukast Sodium Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Montelukast Sodium Market, by Product Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Dosage Form
  • Figure 9. Global Montelukast Sodium Market, by Dosage Form, 2022 & 2032 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Montelukast Sodium Market, by Application, 2022 & 2032 (USD Million)
  • Figure 12. Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Montelukast Sodium Market